Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ·Healthcare·Biotechnology
$13.33
-7.30%
Mkt Cap $408.72M
Analyst Ratings
No recent rating data.
Price Target (14 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+87.5%
Consensus $25.00 vs current $13.33